Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Complications of Rifampin-combined Antibiotic Therapy for Staphylococcal Periprosthetic Joint Infections（PJI）: A Multicenter, Randomized Controlled Trial

NCT07313215 is registered in ClinicalTrials.gov with First Affiliated Hospital of Fujian Medical University as lead sponsor.

NCT NCT07313215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07313215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Complications of Rifampin-combined Antibiotic Therapy for Staphylococcal Periprosthetic Joint Infections（PJI）: A Multicenter, Randomized Controlled Trial
Lead sponsor
First Affiliated Hospital of Fujian Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
November 13, 2025
Completion date
December 18, 2027
Enrollment
428 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

periprosthetic joint infection